Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to the process by which external sounds are captured, processed, and converted into electrical signals by a cochlear implant sound processor, then transmitted to an array of electrodes implanted in the cochlea. These electrodes directly stimulate auditory nerve fibers, bypassing damaged sensory hair cells, allowing individuals with severe-to-profound sensorineural hearing loss to perceive environmental sounds and speech[1][2][3][4][5]. The system comprises external (microphone, speech processor, transmitter) and internal (receiver/stimulator, electrode array) components. The sound processor divides incoming signals into frequency bands, mimics cochlear tonotopy, and uses modulated electrical pulse trains to activate specific locations along the cochlea[2]. This process depends on device mapping, neural survival, and individualized programming, but remains limited in noisy environments and in music fidelity due to the constraints of electrical stimulation and the number/location of surviving auditory neurons[2]. Cochlear implant technology is a medical device rather than a molecular drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Environmental sound processing via cochlear implant.